User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 5 results.
    • Journal article
    Innovations 2022 en chirurgie hépato-bilio-pancréatique
    Marique, Lancelot[UCL] De Cuyper, Astrid[UCL] Annet, Laurence[UCL] Dragean, Cristina Anca[UCL] Goffette, Pierre[UCL] Hoton, Delphine[UCL] Lhommel, Renaud[UCL] Van Ooteghem, Geneviève[UCL] Borbath, Ivan[UCL] Hubert, Catherine[UCL] (2023) Louvain médical — Vol. 142, no.2, p. 69-80 (2023)
    • Journal article
    Cone-beam computed tomography-guided online-adaptive radiotherapy for inoperable right colon cancer: First in human.
    Pierrard, Julien[UCL] Dumont, Damien[UCL] Dechambre, David[UCL] Van den Eynde, Marc[UCL] De Cuyper, Astrid[UCL] Van Ooteghem, Geneviève[UCL] (2023) Technical innovations & patient support in radiation oncology — Vol. 28, p. 100220 [1-5] (2023)
    • Speech
    2237P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Translational analyses of the AVETUXIRI phase II trial
    Huyghe, Nicolas[UCL] Benidovskaya, Elena[UCL] Masoodi, Tariq Carrasco, Javier De Cuyper, Astrid[UCL] Sinapi, Isabelle Vempalli, Fazulur Verstraelen, Eleonore Goffette, Pierre[UCL] Ghaye, Benoît[UCL] Papier, M. Bedognetti, Davide van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jérôme Van den Eynde, Marc[UCL] (2023) ESMO Congress 2023 — (Spain) Madrid
    • Speech
    635P Avelumab (AVE) combined with cetuximab (CET) and irinotecan (IRI) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): The AVETUXIRI phase II study
    Van den Eynde, Marc[UCL] Huyghe, Nicolas[UCL] Sinapi, Isabelle De Cuyper, Astrid[UCL] Verstraelen, Eleonore Goffette, Pierre[UCL] Ghaye, Benoît[UCL] Papier, Matthias Bedognetti, Davide van Maanen, Aline[UCL] Castella, Marie-Laure[UCL] Galon, Jerôme Carrasco, Javier (2023) ESMO Congress 2023 — (Spain) Madrid
    • Speech
    599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)
    Carrasco, Javier Beniuga, Gabriela[UCL] Mourin, Anne[UCL] Baldin, Paméla[UCL] Sinapi, Isabelle Schroeder, David De Cuyper, Astrid[UCL] Sclafani, Francesco Hendlisz, Alain van Laethem, Jean-Luc Boulanger, Anne-Sophie Van Ooteghem, Geneviève[UCL] Dermine, Alexandre Delmarcelle, Sophie Huyghe, Nicolas[UCL] Bar, Isabelle Van den Eynde, Marc[UCL] (2023) ESMO Congress 2023 — (Spain) Madrid